Foresite Capital Management II’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-877,134
| Closed | -$3.41M | – | 16 |
|
2017
Q1 | $3.41M | Sell |
877,134
-17,561
| -2% | -$68.3K | 1.46% | 7 |
|
2016
Q4 | $3.34M | Sell |
894,695
-5,460
| -0.6% | -$20.4K | 1.68% | 6 |
|
2016
Q3 | $3.74M | Hold |
900,155
| – | – | 1.78% | 7 |
|
2016
Q2 | $4.18M | Buy |
900,155
+12,354
| +1% | +$57.3K | 2.86% | 9 |
|
2016
Q1 | $2.93M | Buy |
887,801
+13,800
| +2% | +$45.5K | 1.43% | 14 |
|
2015
Q4 | $2.98M | Buy |
874,001
+165,669
| +23% | +$565K | 1% | 16 |
|
2015
Q3 | $2.58M | Hold |
708,332
| – | – | 0.78% | 17 |
|
2015
Q2 | $3.52M | Hold |
708,332
| – | – | 1.24% | 17 |
|
2015
Q1 | $5.69M | Buy |
+708,332
| New | +$5.69M | 3.37% | 7 |
|